Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tradipitant in Atopic Dermatitis (EPIONE)
NCT03568331Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tradipitant in atopic dermatitis (AD), sponsored by Vanda Pharmaceuticals Inc.. Started Jul 2018; status: completed.
02
Drugs
tradipitant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03568331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03568331.